healthcare (6241) scientific (619) resistance (178) antimicrobial (115) antibiotics (98) antibiotic (61)
Addressing a Major Unmet Need in Overcoming Antibiotic Resistance Allecra Therapeutics, founded in 2013, is a private, clinical-stage biopharmaceutical company developing novel therapies to combat antibiotic resistance by overcoming emergent resistance mechanisms. Lead product candidate, cefepime/enmetazobactam,has shown superiority over standard of care in patients with complicated urinary tract infections (cUTIs) in a randomized, controlled Phase 3 trial, and the Company is preparing submissions for marke
Allecra’s management team includes:
The team is supported by a Supervisory Board with strong industry and investment experience: Bert Tjeenk Willink (Chairman), Iain Buchanan, Henry Chen, Olivier Litzka, Holger Reithinger and Jason Rushton.